Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Hemolytic-Uremic Syndrome in childhood.

Vaisbich MH.

J Bras Nefrol. 2014 Apr-Jun;36(2):208-20. Review. English, Portuguese.

2.

Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Wada H, Matsumoto T, Yamashita Y.

Semin Thromb Hemost. 2014 Nov;40(8):866-73. doi: 10.1055/s-0034-1395154. Epub 2014 Nov 6. Review.

PMID:
25377323
3.

Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome.

Tsai HM.

Am J Med. 2013 Mar;126(3):200-9. doi: 10.1016/j.amjmed.2012.09.006. Review.

PMID:
23410558
4.
5.

Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.

Cataland SR, Wu HM.

Eur J Intern Med. 2013 Sep;24(6):486-91. doi: 10.1016/j.ejim.2013.05.007. Epub 2013 Jun 2. Review.

PMID:
23739653
6.

Diagnosis and management of complement mediated thrombotic microangiopathies.

Cataland SR, Wu HM.

Blood Rev. 2014 Mar;28(2):67-74. doi: 10.1016/j.blre.2014.01.003. Epub 2014 Jan 31. Review.

PMID:
24534133
7.

Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.

Belingheri M, Possenti I, Tel F, Paglialonga F, Testa S, Salardi S, Ardissino G.

Pediatrics. 2014 Jun;133(6):e1769-71. doi: 10.1542/peds.2013-2921. Epub 2014 May 19.

PMID:
24843058
8.

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.

Scully M, Goodship T.

Br J Haematol. 2014 Mar;164(6):759-66. doi: 10.1111/bjh.12718. Epub 2014 Jan 6. Review.

9.

Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura.

Noris M, Remuzzi G.

Semin Nephrol. 2010 Jul;30(4):395-408. doi: 10.1016/j.semnephrol.2010.06.006.

PMID:
20807612
10.

Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.

Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B.

Pediatrics. 2014 Jun;133(6):e1764-8. doi: 10.1542/peds.2013-1594.

PMID:
24843055
11.

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

Cataland SR, Holers VM, Geyer S, Yang S, Wu HM.

Blood. 2014 Jun 12;123(24):3733-8. doi: 10.1182/blood-2013-12-547067. Epub 2014 Apr 2.

12.

Complement activation in diseases presenting with thrombotic microangiopathy.

Meri S.

Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Review.

PMID:
23743117
13.

Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.

Laurence J.

Clin Adv Hematol Oncol. 2012 Oct;10(10 Suppl 17):1-12. Review.

PMID:
23187605
14.

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

Clark WF.

Semin Dial. 2012 Mar-Apr;25(2):214-9. doi: 10.1111/j.1525-139X.2011.01035.x. Epub 2012 Feb 7. Review.

PMID:
22309967
16.

Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.

Fakhouri F, Frémeaux-Bacchi V, Loirat C.

Eur J Intern Med. 2013 Sep;24(6):492-5. doi: 10.1016/j.ejim.2013.05.008. Epub 2013 Jun 5. Review.

PMID:
23756030
17.

[Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].

Gaggl M, Aigner C, Sunder-Plassmann G, Schmidt A.

Med Klin Intensivmed Notfmed. 2016 Jun;111(5):434-9. doi: 10.1007/s00063-016-0176-6. Epub 2016 Jun 2. German.

PMID:
27255224
18.

Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.

Christmann M, Hansen M, Bergmann C, Schwabe D, Brand J, Schneider W.

Pediatrics. 2014 Jun;133(6):e1759-63. doi: 10.1542/peds.2013-1787.

PMID:
24843059
19.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH.

Curr Opin Hematol. 2010 Sep;17(5):432-8. doi: 10.1097/MOH.0b013e32833cae86. Review.

PMID:
20613506
20.

Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.

Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.

J Med Case Rep. 2014 Sep 14;8:307. doi: 10.1186/1752-1947-8-307.

Supplemental Content

Support Center